The influence of fibrinogen degradation products on the reptilase-time of plasma.
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D002848:Chromatography, DEAE-Cellulose; D005337:Fibrin / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism*; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use; D005998:Glycine / Q000032:analysis; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009203:Myocardial Infarction / Q000188:drug therapy; D010447:Peptide Hydrolases / Q000032:analysis / Q000494:pharmacology*; D011517:Prothrombin Time; D011817:Rabbits / Q000276:immunology; D012911:Snakes; D013917:Thrombin / Q000494:pharmacology; D014688:Venoms
D005343:Fibrinolytic Agents; D014688:Venoms; D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin; D010447:Peptide Hydrolases; D013917:Thrombin; D005998:Glycine